1.0Sentinel Biohttps://sentinelbio.orgNicole SannaFourth Eon Bio – Sentinel Biorich600338<blockquote class="wp-embedded-content" data-secret="FodrvgXZSY"><a href="https://sentinelbio.org/grant/fourth-eon-bio-2/">Fourth Eon Bio</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://sentinelbio.org/grant/fourth-eon-bio-2/embed/#?secret=FodrvgXZSY" width="600" height="338" title="“Fourth Eon Bio” — Sentinel Bio" data-secret="FodrvgXZSY" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://sentinelbio.org/wp-includes/js/wp-embed.min.js
/* ]]> */
</script>
We provided $418,000 to Fourth Eon Bio to advance function-based screening in the nucleic acid synthesis industry. This includes evaluating whether AI-powered biological design tools can generate threats that evade current screening methods and developing new approaches to detect them. Fourth Eon Bio will also continue to build consensus across synthesis providers, screening tool developers, […]https://sentinelbio.org/wp-content/uploads/2024/12/Sentinel-Bio_Sharecard.png50012626